%0 Journal Article
%T Diagnostic delay and its associated factors in Chinese axial spondyloarthritis: A single-center study of 1295 patients.
%A Zheng X
%A Chen Z
%A Wu X
%A Xie Y
%A Wu J
%A Xiao M
%A Yang M
%A Tu L
%A Cao S
%A Wei Q
%A Gu J
%J Int J Rheum Dis
%V 27
%N 1
%D 2024 Jan 15
%M 37965927
%F 2.558
%R 10.1111/1756-185X.14975
%X <B>OBJECTIVE: </B>To delineate the landscape of diagnostic delay in Chinese axial spondyloarthritis (axSpA), investigate its associated factors, and explore its potential impact on medication modalities.<BR><B>METHODS: </B>A total of 1295 patients fulfilling the ASAS classification criteria were obtained. Demographic and clinical data were collected through face-to-face interviews, based on predesigned questionnaires and available medical records. Logistic regression analyses under univariate and multivariable model were performed, using the median of diagnostic delay as the cut-off point for group classification. Differences between early- and late-diagnosed groups were subsequently compared by the Pearson chi-square test or Mann-Whitney U test.<BR><B>RESULTS: </B>Of 1295 axSpA patients, 80.3% were male and the median of disease duration was 8.0 years. The median (IQR) diagnostic delay in Chinese axSpA was 3.0 (1.0 ~ 7.0) years and 24.8% of them reported a history of misdiagnosis. Older age at onset (OR = 0.97, p < .001) and higher education attainment (p = .001) were correlated with early diagnosis of axSpA, whereas coming from less developed areas (p = .002), a history of peripheral arthritis at the time of diagnosis (OR = 1.58, p = .002) and history of misdiagnosis (OR = 1.98, p < .001) increased the risk of diagnostic delay. Oral medication modalities were similar between two groups, but the proportion with no medication ever was higher in the late-diagnosed group (26.5% vs. 20.7%, p = .02).<BR><B>CONCLUSIONS: </B>Our findings depicted a detailed spectrum of diagnostic delay in Chinese axSpA, verified five associated factors that may help facilitate timely diagnosis of axSpA, and pinpointed that timely medication was unsatisfying, especially in the late diagnosis group.